Hironic Boosts Corporate Value as CEO Jinwoo Lee Acquires Company Shares

Hironic, a company specializing in aesthetic medical devices, is taking steps to enhance its corporate value, including the acquisition of its own shares.

On August 5, Hironic announced that CEO Jinwoo Lee had acquired 21,271 common shares of the company through on-market purchases. As a result, CEO Lee's shareholding increased from 3,599,618 shares to 3,620,889 shares. Considering that in June, Hironic canceled 3,995,317 treasury shares, CEO Lee's ownership percentage has risen from 19.36% to 21.05%.

Hironic explained that this on-market purchase aims to strengthen responsible management and boost corporate value. The company is also pursuing shareholder return initiatives, including the retirement of all treasury shares held following the resumption of trading and the issuance of its first-ever quarterly dividend since its founding.

Meanwhile, Hironic recently obtained domestic product approvals for its next-generation multi-functional medical device 'SYNERJET PRO' and its second-generation microwave medical device 'MIGLOU.' The company continues its global business expansion, having signed exclusive distribution agreements in Singapore and the United Arab Emirates (UAE).

CEO Lee commented, "This on-market share purchase was made based on my confidence in Hironic’s growth potential and future corporate value. We will continue to enhance both company and shareholder value through stronger competitiveness in new products, global market expansion, and ongoing shareholder return policies."

This content was produced with the assistance of AI translation services.